This inventor holds 1 USPTO granted patent. Top assignee: Nanjing Noratech Pharmaceuticals Co., Ltd. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Yunzhe Sun: Innovator in Pharmaceutical Formulation
Introduction
Yunzhe Sun is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical formulation, particularly in the development of injectable medications. His work focuses on improving the efficacy and stability of drug formulations.
Latest Patents
Yunzhe Sun holds a patent for an "Aripiprazole injectable suspension formulation having prolonged shelf life." This invention pertains to a pharmaceutical formulation that enhances the shelf life of aripiprazole, a medication used in treating schizophrenia and related diseases. The formulation aims to provide a more stable and effective treatment option for patients.
Career Highlights
Yunzhe Sun is associated with Nanjing Noratech Pharmaceuticals Co., Ltd., where he applies his expertise in pharmaceutical sciences. His innovative approach to drug formulation has positioned him as a key figure in the industry, contributing to advancements in medication stability and patient care.
Collaborations
Yunzhe has collaborated with notable colleagues, including Qi Peng and Cheng-Gang Lin. Their combined efforts in research and development have furthered the understanding and application of pharmaceutical formulations.
Conclusion
Yunzhe Sun's contributions to the field of pharmaceutical formulation exemplify the impact of innovation in healthcare. His work not only enhances the stability of medications but also improves treatment options for patients suffering from schizophrenia and related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile